Adcock Ingram Holdings Ltd. is a pharmaceutical company, which engages in the manufacture, marketing, and distribution of healthcare products to both private and public sectors of the market. The company is headquartered in Midrand, Gauteng. The company went IPO on 2008-08-25. The firm manufactures, markets, and distributes a range of healthcare and consumer products, and is a supplier to the private sector. Its segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the fast-moving consumer goods (FMCG) space. The OTC segment focuses on brands sold predominantly in pharmacies. The Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. The Other segment includes shared services and other support services, including regulatory services in India, as well as the investment in the joint venture and cash and bank overdraft balances, which are managed on a central basis in Southern Africa.
Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
06/30/2025
06/30/2024
06/30/2023
06/30/2022
06/30/2021
Hasılat
9,760
9,760
9,643
9,131
8,705
7,776
Hasılat Artışı (YoY)
1%
1%
6%
5%
12%
6%
Satınalma Maliyeti
6,540
7,033
6,893
6,422
6,108
5,648
Brüt Kâr
3,219
2,726
2,750
2,709
2,597
2,128
Satış, Genel ve İdari
2,074
1,478
1,475
1,484
1,437
1,134
Araştırma ve Geliştirme
--
--
--
--
--
--
İşletme Giderleri
2,137
1,583
1,568
1,574
1,532
1,233
Diğer Finansman Gelirleri (Giderleri)
--
-94
-70
-30
-17
-19
Kâr Öncesi Gelir
1,141
1,141
1,124
1,205
1,101
905
Kira Vergisi Gideri
283
283
310
307
301
243
Net Kâr
858
858
814
898
800
657
Net Income Growth
Kâr Artışı
5%
5%
-9%
12%
22%
-3%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
150.08
150.29
154.63
163.75
164.76
165.97
Hisse Değişimi (Yıllık Üst Üste)
-2%
-3%
-6%
-1%
-1%
-2%
EPS (Diluted)
5.71
5.71
5.26
5.48
4.85
3.96
EPS Artışı
7%
9%
-4%
13%
23%
0%
Öz sermaye akışı
139
139
437
233
327
69
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
32.98%
27.93%
28.51%
29.66%
29.83%
27.36%
Faaliyet Kâr Marjı
11.08%
11.7%
12.25%
12.43%
12.22%
11.5%
Kâr Marjı
8.79%
8.79%
8.44%
9.83%
9.19%
8.44%
Özsermaye Karlılık Oranı
1.42%
1.42%
4.53%
2.55%
3.75%
0.88%
EBITDA
--
1,247
1,274
1,224
1,155
992
EBITDA Marjinali
--
12.77%
13.21%
13.4%
13.26%
12.75%
D&A EBITDA için
--
105
92
89
91
97
Faaliyet Kârı
1,082
1,142
1,182
1,135
1,064
895
Faaliyet Kâr Marjı
11.08%
11.7%
12.25%
12.43%
12.22%
11.5%
Verilen Vergi Oranı
24.8%
24.8%
27.58%
25.47%
27.33%
26.85%
Follow-Up Questions
Adcock Ingram Holdings Ltd'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Adcock Ingram Holdings Ltd'in toplam varlıkları $8,735 olup, net kâr $858'dir.
AIHLF'ün temel finansal oranları nelerdir?
Adcock Ingram Holdings Ltd'in cari oranı 3, net kâr marjı 8.79, hisse başına satış $64.93'dir.
Adcock Ingram Holdings Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Adcock Ingram Holdings Ltd en büyük gelir kaynağı Prescription olup, en son kar bildiriminde geliri 3,429,809,000 dir. Coğrafi olarak, Southern Africa , Adcock Ingram Holdings Ltd için ana pazar olup, geliri 9,643,128,000 dir.
Adcock Ingram Holdings Ltd kârlı mı?
evet, son mali tablolara göre Adcock Ingram Holdings Ltd'in net kâr $858'dir.
Adcock Ingram Holdings Ltd'in herhangi bir yükümlülüğü var mı?